Click for best price
CART Cell Immunotherapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Immunotherapy. This report contains market size and forecasts of CAR-T Cell Immunotherapy in global, including the following market information:
Global CAR-T Cell Immunotherapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global CAR-T Cell Immunotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CD19 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CAR-T Cell Immunotherapy include Novartis AG, Kite Pharma, JW Therapeutics and Shanghai Fosun Pharmaceutical Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CAR-T Cell Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR-T Cell Immunotherapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global CAR-T Cell Immunotherapy Market Segment Percentages, by Type, 2022 (%)
CD19
CD22
Other
Global CAR-T Cell Immunotherapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global CAR-T Cell Immunotherapy Market Segment Percentages, by Application, 2022 (%)
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
High Grade B Cell Lymphoma
DLBCL
Other
Global CAR-T Cell Immunotherapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global CAR-T Cell Immunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR-T Cell Immunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR-T Cell Immunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Kite Pharma
JW Therapeutics
Shanghai Fosun Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR-T Cell Immunotherapy, market overview.
Chapter 2: Global CAR-T Cell Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of CAR-T Cell Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR-T Cell Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
CAR-T Cell Immunotherapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR-T Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR-T Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR-T Cell Immunotherapy Overall Market Size
2.1 Global CAR-T Cell Immunotherapy Market Size: 2022 VS 2032
2.2 Global CAR-T Cell Immunotherapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR-T Cell Immunotherapy Players in Global Market
3.2 Top Global CAR-T Cell Immunotherapy Companies Ranked by Revenue
3.3 Global CAR-T Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Cell Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR-T Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR-T Cell Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Cell Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Cell Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR-T Cell Immunotherapy Market Size Markets, 2022 & 2032
4.1.2 CD19
4.1.3 CD22
4.1.4 Other
4.2 By Type - Global CAR-T Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global CAR-T Cell Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global CAR-T Cell Immunotherapy Revenue, 2024-2032
4.2.3 By Type - Global CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR-T Cell Immunotherapy Market Size, 2022 & 2032
5.1.2 Relapsed or Refractory Mantle Cell Lymphoma (MCL)
5.1.3 High Grade B Cell Lymphoma
5.1.4 DLBCL
5.1.5 Other
5.2 By Application - Global CAR-T Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global CAR-T Cell Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global CAR-T Cell Immunotherapy Revenue, 2024-2032
5.2.3 By Application - Global CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global CAR-T Cell Immunotherapy Market Size, 2022 & 2032
6.2 By Region - Global CAR-T Cell Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global CAR-T Cell Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global CAR-T Cell Immunotherapy Revenue, 2024-2032
6.2.3 By Region - Global CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America CAR-T Cell Immunotherapy Revenue, 2018-2032
6.3.2 US CAR-T Cell Immunotherapy Market Size, 2018-2032
6.3.3 Canada CAR-T Cell Immunotherapy Market Size, 2018-2032
6.3.4 Mexico CAR-T Cell Immunotherapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe CAR-T Cell Immunotherapy Revenue, 2018-2032
6.4.2 Germany CAR-T Cell Immunotherapy Market Size, 2018-2032
6.4.3 France CAR-T Cell Immunotherapy Market Size, 2018-2032
6.4.4 U.K. CAR-T Cell Immunotherapy Market Size, 2018-2032
6.4.5 Italy CAR-T Cell Immunotherapy Market Size, 2018-2032
6.4.6 Russia CAR-T Cell Immunotherapy Market Size, 2018-2032
6.4.7 Nordic Countries CAR-T Cell Immunotherapy Market Size, 2018-2032
6.4.8 Benelux CAR-T Cell Immunotherapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia CAR-T Cell Immunotherapy Revenue, 2018-2032
6.5.2 China CAR-T Cell Immunotherapy Market Size, 2018-2032
6.5.3 Japan CAR-T Cell Immunotherapy Market Size, 2018-2032
6.5.4 South Korea CAR-T Cell Immunotherapy Market Size, 2018-2032
6.5.5 Southeast Asia CAR-T Cell Immunotherapy Market Size, 2018-2032
6.5.6 India CAR-T Cell Immunotherapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America CAR-T Cell Immunotherapy Revenue, 2018-2032
6.6.2 Brazil CAR-T Cell Immunotherapy Market Size, 2018-2032
6.6.3 Argentina CAR-T Cell Immunotherapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Cell Immunotherapy Revenue, 2018-2032
6.7.2 Turkey CAR-T Cell Immunotherapy Market Size, 2018-2032
6.7.3 Israel CAR-T Cell Immunotherapy Market Size, 2018-2032
6.7.4 Saudi Arabia CAR-T Cell Immunotherapy Market Size, 2018-2032
6.7.5 UAE CAR-T Cell Immunotherapy Market Size, 2018-2032
7 CAR-T Cell Immunotherapy Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG CAR-T Cell Immunotherapy Major Product Offerings
7.1.4 Novartis AG CAR-T Cell Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Kite Pharma
7.2.1 Kite Pharma Company Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma CAR-T Cell Immunotherapy Major Product Offerings
7.2.4 Kite Pharma CAR-T Cell Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Kite Pharma Key News & Latest Developments
7.3 JW Therapeutics
7.3.1 JW Therapeutics Company Summary
7.3.2 JW Therapeutics Business Overview
7.3.3 JW Therapeutics CAR-T Cell Immunotherapy Major Product Offerings
7.3.4 JW Therapeutics CAR-T Cell Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 JW Therapeutics Key News & Latest Developments
7.4 Shanghai Fosun Pharmaceutical Group
7.4.1 Shanghai Fosun Pharmaceutical Group Company Summary
7.4.2 Shanghai Fosun Pharmaceutical Group Business Overview
7.4.3 Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Major Product Offerings
7.4.4 Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Shanghai Fosun Pharmaceutical Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR-T Cell Immunotherapy Market Opportunities & Trends in Global Market
Table 2. CAR-T Cell Immunotherapy Market Drivers in Global Market
Table 3. CAR-T Cell Immunotherapy Market Restraints in Global Market
Table 4. Key Players of CAR-T Cell Immunotherapy in Global Market
Table 5. Top CAR-T Cell Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR-T Cell Immunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR-T Cell Immunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR-T Cell Immunotherapy Product Type
Table 9. List of Global Tier 1 CAR-T Cell Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR-T Cell Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - CAR-T Cell Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR-T Cell Immunotherapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - CAR-T Cell Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR-T Cell Immunotherapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global CAR-T Cell Immunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR-T Cell Immunotherapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2024-2032
Table 30. Novartis AG Company Summary
Table 31. Novartis AG CAR-T Cell Immunotherapy Product Offerings
Table 32. Novartis AG CAR-T Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Kite Pharma Company Summary
Table 35. Kite Pharma CAR-T Cell Immunotherapy Product Offerings
Table 36. Kite Pharma CAR-T Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Kite Pharma Key News & Latest Developments
Table 38. JW Therapeutics Company Summary
Table 39. JW Therapeutics CAR-T Cell Immunotherapy Product Offerings
Table 40. JW Therapeutics CAR-T Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. JW Therapeutics Key News & Latest Developments
Table 42. Shanghai Fosun Pharmaceutical Group Company Summary
Table 43. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Product Offerings
Table 44. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Shanghai Fosun Pharmaceutical Group Key News & Latest Developments
List of Figures
Figure 1. CAR-T Cell Immunotherapy Segment by Type in 2022
Figure 2. CAR-T Cell Immunotherapy Segment by Application in 2022
Figure 3. Global CAR-T Cell Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR-T Cell Immunotherapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global CAR-T Cell Immunotherapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR-T Cell Immunotherapy Revenue in 2022
Figure 8. By Type - Global CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 16. US CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 20. Germany CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 21. France CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 28. China CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 32. India CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 34. Brazil CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa CAR-T Cell Immunotherapy Revenue Market Share, 2018-2032
Figure 37. Turkey CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE CAR-T Cell Immunotherapy Revenue, (US$, Mn), 2018-2032
Figure 41. Novartis AG CAR-T Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Kite Pharma CAR-T Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. JW Therapeutics CAR-T Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Shanghai Fosun Pharmaceutical Group CAR-T Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
